Suppr超能文献

索引性肝失代偿:经放射性核素闪烁扫描诊断为无临床显著门静脉高压体征的肝性胸水。

Index Hepatic Decompensation: Hepatic Hydrothorax Without Signs of Clinically Significant Portal Hypertension Diagnosed With Radioisotope Scintigraphy.

作者信息

Gunderson Alisia C, Andres Brendan, Gunderson Joseph R, Sabottke Carl, Savir-Baruch Bital, Ainapurapu Bujji

机构信息

Department of Medicine, University of Arizona College of Medicine, Tucson, AZ.

Division of Gastroenterology and Liver Disease, University Hospitals Cleveland Medical Center/Case Western Reserve University, Cleveland, OH.

出版信息

ACG Case Rep J. 2025 Sep 4;12(9):e01819. doi: 10.14309/crj.0000000000001819. eCollection 2025 Sep.

Abstract

Hepatic hydrothorax (HH) occurs in 4%-12% of patients with cirrhosis and rarely presents without accompanying evidence of clinically significant portal hypertension (CSPH). We report the case of a 65-year-old man with cirrhosis without prior decompensation, congestive heart failure, and recurrent right-sided pleural effusion. CSPH was not otherwise observed despite thorough laboratory, radiologic, and endoscopic evaluation. However, pleural fluid analysis revealed a serum effusion albumin gradient of 1.6, raising suspicion for a hepatic etiology. Suspected HH was diagnosed by technetium-99m sulfur colloid peritoneal cavity scintigraphy. As the index decompensating event, the patient's HH initiated a liver transplant evaluation in the absence of other evidence of CSPH.

摘要

肝性胸水(HH)见于4%-12%的肝硬化患者,且很少在无临床显著门静脉高压(CSPH)相关证据的情况下出现。我们报告一例65岁男性患者,患有肝硬化,此前无失代偿、充血性心力衰竭及复发性右侧胸腔积液。尽管进行了全面的实验室、影像学和内镜评估,但未发现其他CSPH证据。然而,胸水分析显示血清-胸水白蛋白梯度为1.6,这引发了对肝源性病因的怀疑。通过锝-99m硫胶体腹腔闪烁扫描术诊断为疑似HH。作为首次失代偿事件,该患者的HH在无其他CSPH证据的情况下启动了肝移植评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f36e/12410309/84cd9c184499/ac9-12-e01819-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验